Archive · 4 Sep 2025
Supreme Court Questions Enforcement of Pharma Marketing Rules
The Supreme Court is looking into whether drug companies are behaving unethically when they market their products.
They are checking if the rules, called UCPMP 2024, are actually being followed.
The court is concerned that these rules might not be doing enough to stop companies from offering gifts or other incentives to doctors to prescribe their drugs.
A group called 'Federation of Medical and Sales Representatives Association of India' brought the issue to the court.
They want the court to create stronger guidelines to prevent unethical marketing practices and protect patients.
The Supreme Court is reviewing the implementation of existing marketing norms for pharmaceutical firms.
The court is hearing a plea against unethical marketing practices in the pharma industry.
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 is already in place.
The court expressed concerns about whether the existing rules are being effectively enforced.
The case was posted for October 7, likely requiring more time for deliberation.
- Who
- Supreme Court of India, pharmaceutical companies
- What
- Hearing on unethical marketing practices
- When
- Thursday; posted for October 7
- Where
- India
- Why
- To address unethical marketing by pharma companies
- Court
- Supreme Court of India
- Subject
- Unethical Pharma Marketing Practices
- Existing Code
- Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024
- Hearing Date
- October 7
- Petitioner
- Federation of Medical and Sales Representatives Association of India
